Sanofi Pasteur plans C$100M R&D facility in Canada
Score one win for Ontario province in the field of economic development. Sanofi Pasteur, the vaccine arm of Sanofi-Aventis, will build a C$100 million R&D facility in Toronto with the province chipping in C$13.9 million through its Biopharmaceutical Investment Program.
Researchers will target pediatric combination vaccines, pneumococcal protein vaccines and cancer vaccines. Look for the grand opening in 2010.
- check out the AFX report
Related Articles:
Sanofi licenses technology for new TB vaccine. Sanofi report
Maxygen, Sanofi Pasteur ink $24.5M vaccine deal. Sanofi report
Canada's streamlined approval process raises protests. Canada report
Canada's drug market slowing. Market report
Comments (1) | Post a comment Rate it:
Comments
By Anonymous | Posted 1:47pm | May 8, 2008
Bonjour je suis Cristina Dumitru, nous avons analysé votre BLOGUE et nous serions intéressé d'entrer en contact avec vous afin de vous proposer d'être un BLOGUEUR accrédité de PublicationWeb.com.
Nous vous remercions!
Cristina.dumitru@publicationweb.com
Post new comment
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight